1887

Abstract

Orf virus (ORFV) is the type species of the parapoxvirus genus and produces cutaneous pustular lesions in sheep, goats and humans. The genome encodes a polypeptide with remarkable homology to interleukin-10 (IL-10), particularly ovine IL-10, and also to IL-10-like proteins encoded by Epstein–Barr virus (EBV) and equine herpesvirus. IL-10 is a pleiotropic cytokine that can exert either immunostimulatory or immunosuppressive effects on many cell types. We have expressed and purified C-terminal FLAG and His-tagged versions of ORFV-IL-10 and shown that ORFV-IL-10 costimulates murine mast cells (MC/9) and inhibits tumour necrosis factor-α synthesis in activated mouse peritoneal macrophages. Our results demonstrate that although ORFV-IL-10 is structurally similar to EBV-IL-10 it has evolved a different spectrum of activities. EBV-IL-10 does not stimulate the proliferation of thymocytes or mast cells whereas ORFV-IL-10 has both of these activities. Recent studies show that the critical difference in molecular structure of human IL-10 and EBV-IL-10, which may be the basis of their functional differences, is linked to a single amino acid substitution. Consistent with the activity spectrum reported here for ORFV-IL-10, the viral gene encodes the critical amino acid seen in human IL-10. Although the ORFV-IL-10 gene has clearly undergone significant evolutionary change at the nucleotide level compared with ovine IL-10, it has largely retained the polypeptide structure and functional characteristics of its ovine counterpart, suggesting that mutations of the gene to a potentially more potent immunosuppressive form may compromise the co-existence of host and virus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-5-1049
2002-05-01
2020-07-13
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/5/0831049a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-5-1049&mimeType=html&fmt=ahah

References

  1. Achen M. G., Jeltsch M., Kukk E., Makinen T., Vitali A., Wilks A. F., Alitalo K., Stacker S. A.. 1998; Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proceedings of the National Academy of Sciences, USA95:548–555
    [Google Scholar]
  2. Aldwell F. E., Wedlock D. N., Buddle B. M.. 1997; Sequential activation of alveolar macrophages by IFN-γ and LPS is required for enhanced growth inhibition of virulent Mycobacterium bovis but not M. bovis BCG. Immunology and Cell Biology75:161–166
    [Google Scholar]
  3. Bazan J. F.. 1990; Structural design and molecular evolution of a cytokine receptor superfamily. Proceedings of the National Academy of Sciences, USA87:6934–6938
    [Google Scholar]
  4. Bongers M., Liehl E., Barsig J.. 1999; One-step RT–PCR to detect cytokine/chemokine induction in macrophages. Focus (BRL Life Technologies)21:66–68
    [Google Scholar]
  5. Chomczynski P., Sacchi N.. 1987; Single step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Analytical Biochemistry162:156–159
    [Google Scholar]
  6. Ding Y., Qin L., Kotenko S. V., Pestka S., Bromberg J. S.. 2000; A single amino acid determines the immunostimulatory activity of interleukin 10. Journal of Experimental Medicine191:213–223
    [Google Scholar]
  7. Dutia B. M., Hunt P., Sargan D. R., Dalziel R. G., Hopkins J.. 1994; Sequence of sheep interleukin-10 encoding cDNA. Gene149:393–394
    [Google Scholar]
  8. Ealick S. E., Cook W. J., Vijay-Kumar S., Carson M., Nagabhushan T. L., Trotta P. P., Bugg C. E.. 1991; Three-dimensional structure of recombinant interferon-γ. Science252:698–702
    [Google Scholar]
  9. Fei N. F., Castle B. E., Barrett R., Kastelein R., Dang W., Mosmann T. R., Moore K. W., Howard M.. 1990; Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. Journal of Experimental Medicine172:1625–1631
    [Google Scholar]
  10. Fiorentino D. F., Zlotnik A., Mosmann T. R., Howard M., O’Garra A.. 1991; IL-10 inhibits cytokine production by activated macrophages. Journal of Immunology147:3815–3822
    [Google Scholar]
  11. Fleming S. B., McCaughan C. A., Andrews A. E., Nash A. D., Mercer A. A.. 1997; A homolog of interleukin-10 is encoded by the poxvirus orf virus. Journal of Virology71:4857–4861
    [Google Scholar]
  12. Fleming S. B., Haig D. M., Nettleton P., Reid H. W., McCaughan C. A., Wise L. M., Mercer A. A.. 2000; Sequence and functional analysis of a homolog of interleukin-10 encoded by the parapoxvirus orf virus. Virus Genes21:85–90
    [Google Scholar]
  13. Francki R. I. B., Fauquet C. M., Knudson D. L., Brown F.. (editors) 1991; Classification and Nomenclature of viruses. Fifth Report of the International Committee on Taxonomy of Viruses. Archives of Virology . Supplementum 2
    [Google Scholar]
  14. Gesser B., Leffers H., Jinquan T., Vestergaard C., Kirstein N., Sindet-Pedersen S., Jensen S. L., Thestrup-Pedersen K., Larsen C. G.. 1997; Identification and functional domains on human interleukin 10. Proceedings of the National Academy of Sciences, USA94:14620–14625
    [Google Scholar]
  15. Greig A., Linklater K. A., Clarke W. A.. 1984; Persistent orf in a ram. Veterinary Record115:149
    [Google Scholar]
  16. Guex N., Peitsch M. C.. 1997; SWISS-MODEL and Swiss-PdbViewer: an environment for comparative protein modelling. Electrophoresis18:2714–2723
    [Google Scholar]
  17. Guex N., Diemand A., Peitsch M. C.. 1999; Protein modelling for all. Trends in Biochemical Sciences24:364–367
    [Google Scholar]
  18. Ho A. S., Wei S. H., Mui A. L., Miyajima A., Moore K. W.. 1995; Functional regions of the mouse interleukin-10 receptor cytoplasmic domain. Molecular and Cellular Biology15:5043–5053
    [Google Scholar]
  19. Kotenko S. V., Krause C. D., Isotova L. S., Pollack B. P., Wu W., Pestka S.. 1997; Identification and functional characterisation of a second chain of the interleukin-10 receptor complex. EMBO Journal18:5894–5903
    [Google Scholar]
  20. Kotenko S. V., Saccani S., Izotova L. S., Mirochnitchenko O. V., Pestka S.. 2000; Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proceedings of the National Academy of Sciences, USA97:1695–1700
    [Google Scholar]
  21. Laemmli U. K.. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature227:680–685
    [Google Scholar]
  22. Lee L. G., Connell C. R., Bloch W.. 1993; Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Research21:3761–3766
    [Google Scholar]
  23. Liu Y., de Waal Malefyt R., Briere F., Parham C., Bridon J., Banchereau J., Moore K. W., Xu J.. 1997; The EBV IL-10 homologue is a selective agonist with impaired binding to the IL-10 receptor. Journal of Immunology158:604–613
    [Google Scholar]
  24. McKeever D. J.. 1986; Studies of the immunology and epidemiology of orf . PhD thesis University of; Edinburgh, UK:
  25. MacNeil I. A., Suda T., Moore K. W., Mosmann T. R., Zlotnik A.. 1990; IL-10, a novel growth cofactor for mature and immature T cells. Journal of Immunology145:4167–4173
    [Google Scholar]
  26. Martin H. M., Nash A. D., Andrews A. E.. 1995; Cloning and characterisation of an ovine interleukin-10 encoding cDNA. Gene159:187–191
    [Google Scholar]
  27. Matathias A., Fox D., Crouse J.. 1999; SuperScript II RNase H Reverse Transcriptase . Focus Technical Bulletin, Life Technologies18064–3
    [Google Scholar]
  28. Mercer A. A., Lyttle D. J., Whelan E. M., Fleming S. B., Sullivan J. T.. 1995; The establishment of a genetic map of orf virus reveals a pattern of genomic organization that is highly conserved among divergent poxviruses. Virology212:698–704
    [Google Scholar]
  29. Moore K. W., Vieira P., Fiorentino D. F., Trounstine M. L., Khan T. A., Mosmann T. R.. 1990; Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein–Barr virus gene BCRF1. Science248:1230–1234
    [Google Scholar]
  30. Moore K. W., de Waal Malefyte R., Coffman R. L., O’Garra A.. 2001; Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology19:683–765
    [Google Scholar]
  31. Mosmann T. R.. 1994; Properties and functions of interleukin-10. Advances in Immunology56:1–25
    [Google Scholar]
  32. Peitsch M. C.. 1995; Protein modelling by E-mail. BioTechnology13:658–660
    [Google Scholar]
  33. Reineke U., Sabat R., Volk H., Schneider-Mergener J.. 1998; Mapping of the interleukin-10/interleukin-10 receptor combining site. Protein Science7:951–960
    [Google Scholar]
  34. Robinson A. J., Lyttle D. J.. 1992; Parapoxviruses: their biology and potential as recombinant vaccines. In Recombinant Poxvirus pp163–206 Edited by Binns M., Smith G.. Boca Raton: CRC press;
    [Google Scholar]
  35. Robinson A. J., Ellis G., Balassu T.. 1982; The genome of orf virus: restriction endonuclease analysis of viral DNA isolated from lesions of orf virus in sheep. Archives of Virology71:43–55
    [Google Scholar]
  36. Rode H. J., Janssen W., Rosen-Wolff A., Bugert J. J., Thein P., Becker Y., Darai G.. 1993; The genome of equine herpes virus type 2 harbors an interleukin-10 (IL-10)-like gene. Virus Genes7:111–116
    [Google Scholar]
  37. Suzuki T., Tahara H., Narula S., Moore K. W., Robins P. D., Lotze M. T.. 1995; Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. Journal of Experimental Medicine182:477–486
    [Google Scholar]
  38. Thompson-Snipes L., Dhar V., Bond M. W., Mosmann T. R., Moore K. W., Rennick D. M.. 1991; Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. Journal of Experimental Medicine173:507–510
    [Google Scholar]
  39. Thoreau E., Petridou B., Kelly P. A., Mornon J. P.. 1991; Structural symmetry of the extracellular domain of the cytokine/growth hormone/prolactin receptor family and interferon receptors revealed by hydrophobic cluster analysis. FEBS Letters282:26–31
    [Google Scholar]
  40. Vieira P., de Waal-Malefyt R., Dang M.-N., Johnson K. E., Kastelein R., Fiorentino D. F., DeVries J. E., Roncarlo M.-G., Mosmann T. R., Moore K. W.. 1991; Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein–Barr virus open reading frame BCRF1. Proceedings of the National Academy of Sciences, USA88:1172–1176
    [Google Scholar]
  41. Walter M. R., Nagabhushan T. L.. 1995; Crystal structure of interleukin-10 reveals an interferon γ-like fold. Biochemistry34:12118–12125
    [Google Scholar]
  42. Weber-Nordt R. M., Riley J. K., Greenlund A. C., Moore K. W., Darnell J. E., Schreiber R. D.. 1996; Stat3 recruitment by two distinct ligand-induced, tyrosine-phosphorylated docking sites in the interleukin-10 receptor intracellular domain. Journal of Biological Chemistry271:27954–27961
    [Google Scholar]
  43. Zdanov A., Schalk-Hihi C., Gustchina A., Tsang M., Weatherbee J., Wlodawer A.. 1995; Crystal structure of interleukin-10 reveals the functional dimer with an unexpected topological similarity to interferon γ. Structure3:591–601
    [Google Scholar]
  44. Zdanov A., Schalk-Hihi C., Wlodawer A.. 1996; Crystal structure of human interleukin-10 at 1·6 Å resolution and model of a complex with its soluble receptor. Protein Science5:1955–1962
    [Google Scholar]
  45. Zdanov A., Schalk-Hihi C., Menon S., Moore K. W., Wlodawer A.. 1997; Crystal structure of Epstein–Barr virus protein BCRF1, a homolog of cellular interleukin-10. Journal of Molecular Biology268:460–467
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-5-1049
Loading
/content/journal/jgv/10.1099/0022-1317-83-5-1049
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error